1 day ago
1
mohd izzuan
- Viking Therapeutics (NASDAQ:VKTX) is down ~7% in after-hours trading Wednesday after its Q2 bottom line results missed the mark. The company did not report any revenue.
- The biotech saw its net loss widen to ($0.58) from ($0.20) in the year-ago period.
English (US) ·